Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

Hepatitis B virus (HBV) infection is regarded as the main etiological risk factor in the process of hepatocellular carcinoma (HCC), as it promotes an immunosuppressive microenvironment that is partially mediated by the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) signalin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin, Yan, Cong, Zhu, Jiamin, Chen, Xiaobing, Fu, Qihan, Zhang, Hangyu, Tong, Zhou, Liu, Lulu, Zheng, Yi, Zhao, Peng, Jiang, Weiqin, Fang, Weijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270402/
https://www.ncbi.nlm.nih.gov/pubmed/32547550
http://dx.doi.org/10.3389/fimmu.2020.01037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270402/
https://www.ncbi.nlm.nih.gov/pubmed/32547550
http://dx.doi.org/10.3389/fimmu.2020.01037

Ejemplares similares